Influence of Medication Taste on Pediatric Prescribers’ Prescribing Habits

Overview

The purpose of this study is to see if a medication taste test influences the prescribing habits of pediatric prescribers at Mayo Clinic.

Full Title of Study: “Influence of Medication Palatability on Prescribing Habits of Pediatric Prescribers”

Study Type

  • Study Type: Interventional
  • Study Design
    • Allocation: N/A
    • Intervention Model: Single Group Assignment
    • Primary Purpose: Health Services Research
    • Masking: None (Open Label)
  • Study Primary Completion Date: January 2013

Interventions

  • Drug: Taste Test
    • Before the taste test each participant will fill out an informed consent form and an enrollment survey. Each participant will receive 0.5 mL of each study medication in the taste test. During the taste test each medication in a class will be labeled with a color name so as to prevent any bias from preconceived taste perception. They will record their perception of the medications taste on a visual analog scale (VAS). An anaphlyaxis kit will be on hand in case of emergencies. Between samples participants will cleanse their palate with a saltine cracker and 30 mL of water. 5 different classes of medications will be tested. Medications to be sampled and the corresponding dose of the test dose are: Cephalosporins: cefdinir 12.5 mg, cefixime 10 mg Penicillins: penicillin VK 12.5 mg, amoxicillin 12.5 mg Analgesic/antipyretics: acetaminophen 16 mg, ibuprofen 10 mg Steroids: prednisolone 1.5 mg, prednisone 0.5 mg H2 receptor blockers: famotidine 4 mg, ranitidine 7.5 mg

Arms, Groups and Cohorts

  • Experimental: Taste Test

Clinical Trial Outcome Measures

Primary Measures

  • Taste scores on the visual analog scale
    • Time Frame: Change from baseline in taste scores at 3 months
    • Medication taste scores on the visual analog scale before and after a medication tasting will be measured.

Participating in This Clinical Trial

Inclusion Criteria

  • subjects possess prescriptive authority (e.g. MD, nurse practitioner, physician's assistant, medication therapy management pharmacists) – subjects have prescribed at least one of the study medications from one of the medication classes to pediatric patients at an outpatient clinic in the three months preceding the study Exclusion Criteria:

  • subjects do not prescribe any of the tested medications – subject has an allergy to all of the study medications – subject is pregnant or breastfeeding – subject has a medical condition that prevents them from being involved in the taste test Participants are advised to be within or accessible to the Rochester, MN area during study recruitment and accessible afterwards via mail, email or fax.

Gender Eligibility: All

Minimum Age: 18 Years

Maximum Age: N/A

Are Healthy Volunteers Accepted: Accepts Healthy Volunteers

Investigator Details

  • Lead Sponsor
    • Mayo Clinic
  • Provider of Information About this Clinical Study
    • Principal Investigator: Bernard Lee, Principle Investigator – Mayo Clinic
  • Overall Official(s)
    • Bernard Lee, PharmD, RPh, Principal Investigator, Mayo Clinic
    • Ole J Olson, Pharm.D., BCPS, Principal Investigator, Mayo Clinic
    • Michelle J LoTurco, Pharm.D., Study Director, Mayo Clinic

Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.

At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.